Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingmar Jungner

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
BMC Cancer|April 6, 2017
Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohortJennifer C Melvin, Hans Garmo, Lars Holmberg, et al.
European Journal of Preventive Cardiology|November 7, 2015
Chronic kidney disease and 10-year risk of cardiovascular deathMartin J Holzmann, Axel C Carlsson, Niklas Hammar, et al.
International Journal of Molecular Epidemiology and Genetics|June 23, 2012
Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS studyDivya Seth, Hans Garmo, Annette Wigertz, et al.
Ecancermedicalscience|September 14, 2017
Serum biomarkers to predict risk of testicular and penile cancer in AMORISArunangshu Ghoshal, Hans Garmo, Rhonda Arthur, et al.
Breast Cancer Research : BCR|March 8, 2017
Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohortLydia Shackshaft, Mieke Van Hemelrijck, Hans Garmo, et al.
Cancer Causes & Control : CCC|April 26, 2019
Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohortAnneli Essén, Aida Santaolalla, Hans Garmo, et al.
BMC Public Health|July 20, 2013
Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS studyWahyu Wulaningsih, Karl Michaelsson, Hans Garmo, et al.
Cancer Causes & Control : CCC|May 8, 2013
Iron metabolism and risk of cancer in the Swedish AMORIS studyAnjali Gaur, Helen Collins, Wahyu Wulaningsih, et al.
Carcinogenesis|July 2, 2015
Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patientsWahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
International Journal of Cancer|July 28, 2011
Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammationMieke Van Hemelrijck, Ingmar Jungner, Göran Walldius, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
BMC Cancer|April 6, 2017
Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohortJennifer C Melvin, Hans Garmo, Lars Holmberg, et al.
European Journal of Preventive Cardiology|November 7, 2015
Chronic kidney disease and 10-year risk of cardiovascular deathMartin J Holzmann, Axel C Carlsson, Niklas Hammar, et al.
International Journal of Molecular Epidemiology and Genetics|June 23, 2012
Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS studyDivya Seth, Hans Garmo, Annette Wigertz, et al.
Ecancermedicalscience|September 14, 2017
Serum biomarkers to predict risk of testicular and penile cancer in AMORISArunangshu Ghoshal, Hans Garmo, Rhonda Arthur, et al.
Breast Cancer Research : BCR|March 8, 2017
Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohortLydia Shackshaft, Mieke Van Hemelrijck, Hans Garmo, et al.
Cancer Causes & Control : CCC|April 26, 2019
Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohortAnneli Essén, Aida Santaolalla, Hans Garmo, et al.
BMC Public Health|July 20, 2013
Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS studyWahyu Wulaningsih, Karl Michaelsson, Hans Garmo, et al.
Cancer Causes & Control : CCC|May 8, 2013
Iron metabolism and risk of cancer in the Swedish AMORIS studyAnjali Gaur, Helen Collins, Wahyu Wulaningsih, et al.
Carcinogenesis|July 2, 2015
Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patientsWahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
International Journal of Cancer|July 28, 2011
Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammationMieke Van Hemelrijck, Ingmar Jungner, Göran Walldius, et al.
Pageof 7